Coherus BioSciences Statistics
Total Valuation
CHRS has a market cap or net worth of $188.15 million. The enterprise value is $407.73 million.
| Market Cap | 188.15M |
| Enterprise Value | 407.73M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRS has 114.73 million shares outstanding. The number of shares has increased by 58.36% in one year.
| Shares Outstanding | 114.73M |
| Shares Change (YoY) | +58.36% |
| Shares Change (QoQ) | +12.26% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 75.01% |
| Float | 96.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.80 |
| PS Ratio | 0.62 |
| Forward PS | 0.70 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
| Current Ratio | 1.17 |
| Quick Ratio | 1.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.70% |
| Return on Capital (ROIC) | -44.77% |
| Revenue Per Employee | $986,507 |
| Profits Per Employee | -$193,752 |
| Employee Count | 306 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | -380,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.56% in the last 52 weeks. The beta is 0.60, so CHRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -62.56% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 2.32 |
| Relative Strength Index (RSI) | 49.85 |
| Average Volume (20 Days) | 2,024,950 |
Short Selling Information
The latest short interest is 23.04 million, so 20.08% of the outstanding shares have been sold short.
| Short Interest | 23.04M |
| Short Previous Month | 22.20M |
| Short % of Shares Out | 20.08% |
| Short % of Float | 23.85% |
| Short Ratio (days to cover) | 14.90 |
Income Statement
In the last 12 months, CHRS had revenue of $301.87 million and -$59.29 million in losses. Loss per share was -$0.81.
| Revenue | 301.87M |
| Gross Profit | 125.17M |
| Operating Income | -177.98M |
| Pretax Income | -59.67M |
| Net Income | -59.29M |
| EBITDA | -10.90M |
| EBIT | -17.72M |
| Loss Per Share | -$0.81 |
Balance Sheet
The company has $259.78 million in cash and $479.35 million in debt, giving a net cash position of -$219.58 million or -$1.91 per share.
| Cash & Cash Equivalents | 259.78M |
| Total Debt | 479.35M |
| Net Cash | -219.58M |
| Net Cash Per Share | -$1.91 |
| Equity (Book Value) | -81.84M |
| Book Value Per Share | -0.71 |
| Working Capital | 89.17M |
Cash Flow
In the last 12 months, operating cash flow was -$152.92 million and capital expenditures $533,000, giving a free cash flow of -$152.39 million.
| Operating Cash Flow | -152.92M |
| Capital Expenditures | 533,000 |
| Free Cash Flow | -152.39M |
| FCF Per Share | -$1.35 |
Margins
Gross margin is 41.46%, with operating and profit margins of -58.96% and -19.64%.
| Gross Margin | 41.46% |
| Operating Margin | -58.96% |
| Pretax Margin | -19.77% |
| Profit Margin | -19.64% |
| EBITDA Margin | -3.61% |
| EBIT Margin | -5.87% |
| FCF Margin | -50.48% |
Dividends & Yields
CHRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.36% |
| Shareholder Yield | -58.36% |
| Earnings Yield | -31.51% |
| FCF Yield | -80.99% |
Analyst Forecast
The average price target for CHRS is $8.50, which is 418.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 418.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 16.80% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CHRS has an Altman Z-Score of -2.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.12 |
| Piotroski F-Score | 2 |